ATE261733T1 - Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen - Google Patents

Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen

Info

Publication number
ATE261733T1
ATE261733T1 AT00990685T AT00990685T ATE261733T1 AT E261733 T1 ATE261733 T1 AT E261733T1 AT 00990685 T AT00990685 T AT 00990685T AT 00990685 T AT00990685 T AT 00990685T AT E261733 T1 ATE261733 T1 AT E261733T1
Authority
AT
Austria
Prior art keywords
ginkgo
ginseng
composition
cognitive ability
improve cognitive
Prior art date
Application number
AT00990685T
Other languages
English (en)
Inventor
Orlando Petrini
Andrew Scholey
Original Assignee
Pharmaton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaton Sa filed Critical Pharmaton Sa
Application granted granted Critical
Publication of ATE261733T1 publication Critical patent/ATE261733T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00990685T 1999-12-17 2000-12-08 Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen ATE261733T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17250099P 1999-12-17 1999-12-17
US20835700P 2000-05-31 2000-05-31
PCT/EP2000/012426 WO2001043753A2 (en) 1999-12-17 2000-12-08 Combination of ginseng and ginkgo to improve cognitive skills

Publications (1)

Publication Number Publication Date
ATE261733T1 true ATE261733T1 (de) 2004-04-15

Family

ID=26868153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990685T ATE261733T1 (de) 1999-12-17 2000-12-08 Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen

Country Status (15)

Country Link
US (2) US20020015744A1 (de)
EP (1) EP1242105B3 (de)
JP (1) JP2003517016A (de)
AT (1) ATE261733T1 (de)
AU (1) AU3008301A (de)
BR (1) BR0016471A (de)
CA (1) CA2394012A1 (de)
DE (1) DE60009145T3 (de)
DK (1) DK1242105T5 (de)
ES (1) ES2213641T7 (de)
MX (1) MXPA02005938A (de)
NZ (1) NZ520210A (de)
PT (1) PT1242105E (de)
TR (1) TR200400577T4 (de)
WO (1) WO2001043753A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213571A1 (de) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Pflanzenextrakte und deren Anwendung
MXPA05003285A (es) * 2002-09-28 2005-07-05 Boehringer Ingelheim Int Metodo de potenciacion de las habilidades cognitas.
CN1305487C (zh) * 2003-03-28 2007-03-21 北京欧纳尔生物工程技术有限公司 治疗良性前列腺增生症引起排尿障碍的药物组合物及其制法
ATE428312T1 (de) * 2004-01-29 2009-05-15 Indena Spa Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung
US10105405B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
US10105406B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
DE102008020127A1 (de) * 2008-04-22 2009-11-05 Merz Pharma Gmbh & Co. Kgaa Kompartimentspezifische Pflanzenextraktkombination aus Ginkgo biloba- und Ginseng-Extrakt mit Tandemwirkung
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US9956241B2 (en) 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
JP5546851B2 (ja) 2009-12-21 2014-07-09 ライオン株式会社 貧血改善剤及び貧血改善用組成物
US10201577B2 (en) 2017-02-14 2019-02-12 Keyview Labs, Inc. Compositions and methods for enhancing working and long-term memory support using new combination of ginkgo biloba and panax ginseng and associated components

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same

Also Published As

Publication number Publication date
BR0016471A (pt) 2002-08-20
US20020015744A1 (en) 2002-02-07
WO2001043753A3 (en) 2002-04-25
ES2213641T3 (es) 2004-09-01
JP2003517016A (ja) 2003-05-20
EP1242105A2 (de) 2002-09-25
DK1242105T5 (da) 2009-12-07
DE60009145T2 (de) 2004-07-29
US6773729B2 (en) 2004-08-10
EP1242105B3 (de) 2009-08-12
CA2394012A1 (en) 2001-06-21
DE60009145D1 (de) 2004-04-22
WO2001043753A2 (en) 2001-06-21
AU3008301A (en) 2001-06-25
NZ520210A (en) 2004-02-27
PT1242105E (pt) 2004-06-30
US20030064118A1 (en) 2003-04-03
EP1242105B1 (de) 2004-03-17
ES2213641T7 (es) 2010-03-31
TR200400577T4 (tr) 2004-04-21
DE60009145T3 (de) 2010-02-25
MXPA02005938A (es) 2003-10-14
DK1242105T3 (da) 2004-05-10

Similar Documents

Publication Publication Date Title
CA2338091A1 (en) Method of conditioning the skin
ATE261733T1 (de) Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen
ATE262313T1 (de) Kosmetisches mittel enthaltend maulbeerbaumextrakt und retinoide
PT799578E (pt) Preparacao combinada contendo germes enriquecidos com electrolitos
WO2006031555A3 (en) Compositions and methods for treatment of skin discoloration
BR9910251A (pt) Estimulação hematopoiética
ATE272332T1 (de) Nahrungsergänzungsmittel und verfahren zur kosmetischen behandlung unter verwendung von einem polyphenolreichen traubenextrakt
FI965250A0 (fi) Noggrann maetning av koncentration foer en gaskomponent i en gasblandning, i vilken andra komponenter paoverkar koncentrationsbestaemningen
AU304795S (en) Cosmetic case
AU302242S (en) Flashlight
DE60027326D1 (de) Maca und geweih zur steigerung des testosteronspiegels
AU304022S (en) Bottle cap
DE69910990D1 (de) Nahrungsmittel mit biotin und anderen b-vitaminen
HK1045524B (zh) 具有抗痴呆作用的5-羥皂草苷配基衍生物
DE60024392D1 (de) Verringerung des Erscheinungsunterschieds zwischen kodierten und nichkodierten Texteinheiten
AP2000001950A0 (en) Paroxetine maleate.
MXPA05009110A (es) Composiciones coloreadas particuladas y su uso en productos de cuidado personal.
ZA929390B (en) The use of D-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects.
AU6989998A (en) Amino acid compositions and use thereof in clinical nutrition
HU9903098D0 (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
WO2001085126A3 (en) Cosmetic skin care compositions containing pulegone
WO2003059091A3 (de) Verwendung von mit sauerstoff angereichertem wasser
CA101547S (en) Biofilter treatment module
WO2004017971A8 (de) Verwendung von papaverinartigem vasodilatator und pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1242105

Country of ref document: EP